Patient human leukocyte antigen (HLA) genotype may predict response to anti-programmed death receptor 1 (anti-PD1) in advanced melanoma.

Medicine and Dentistry

• Genotype 100%
• Nodular Melanoma 100%
• Human Leukocyte Antigen 100%
• Programmed Death 1 Receptor 100%
• Patient 100%
• Combination Therapy 40%
• Overall Survival 25%
• Homozygosity 15%
• Survival 15%
• Metastatic Melanoma 10%
• Biological Marker 10%
• Predictor 5%
• Host 5%
• Proportional Hazards Model 5%
• Liver Metastasis 5%
• Age 5%
• Survival Rate 5%
• Brain Metastasis 5%
• Electrocorticography 5%
• Oncology 5%
• Gender 5%
• Inpatient 5%
• Assay 5%
• Leukocyte 5%
• Blood 5%

Immunology and Microbiology

• Genotype 100%
• Human Leukocyte Antigen 100%
• Programmed Death 1 Receptor 100%
• Overall Survival 25%
• Homozygosity 15%
• Survival 15%
• Immune Checkpoint Blockade 10%
• Programmed Death-Ligand 1 10%
• Host 5%
• Mutation 5%
• White Blood Cell 5%
• Age 5%
• Survival Rate 5%
• Liver 5%
• Gender 5%
• Brain 5%

Biochemistry, Genetics and Molecular Biology

• Genotyping 100%
• Human Leukocyte Antigen 100%
• Overall Survival 25%
• Homozygosity 15%
• Survival 15%
• Randomized Clinical Trial 10%
• Multivariate Analysis 10%
• Mutation 5%
• Host 5%
• Age 5%
• White Blood Cell 5%
• Germline 5%
• PD-L1 5%
• Survival Rate 5%
• Gender 5%
• DNA 5%